Cardiologists in Nigeria have called for wider cardiovascular screening at primary healthcare centres and lower prices for essential heart medicines as the country faces a growing burden of heart disease. The Nigerian Cardiac Society made the call during activities marking the 2026 World Heart Day in Abuja. The programme, organised around the theme “Don’t Miss A Beat,” included cardiovascular screening, a symposium, as well as school activities focused on heart health.
Professor Amam Mbakwe, a consultant cardiologist and Vice-President of the World Heart Federation, said cardiovascular screening should become part of routine services at the primary healthcare level. She argued that Nigeria cannot depend mainly on specialist doctors and tertiary hospitals to identify and manage the increasing number of people at risk of cardiovascular disease. Mbakwe said existing primary healthcare structures could be used instead of creating a completely separate screening system.
She pointed to the integration of HIV services into primary healthcare as an example of how an existing system could be expanded to provide additional services. According to her, primary healthcare centres should have basic equipment needed to identify common cardiovascular risk factors. These include glucometers for checking blood sugar, weighing scales and facilities for checking urine for protein, alongside routine blood pressure measurements and other appropriate assessments.
The call comes amid concerns over the prevalence of hypertension in Nigeria. The Federal Ministry of Health and Social Welfare has also urged Nigerians to check their blood pressure regularly, describing routine monitoring and consistent treatment as important measures for controlling hypertension. The ministry said the Federal Government had introduced policies and guidelines aimed at improving the early detection, management and prevention of hypertension.
The cost of treatment is another major concern raised by specialists. Professor Enjiroghene Umuerri, Secretary-General of the Nigerian Cardiac Society, said many essential cardiovascular medicines used in Nigeria are imported. According to her, the dependence on imported medicines adds to the cost of treatment for patients.
Umuerri called for greater local production of essential cardiovascular medicines by Nigerian pharmaceutical companies. She said increasing domestic production could reduce the additional costs associated with importing medicines while also creating employment opportunities.